Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: Role in kinin generation in rheumatoid arthritis

Rheumatology

Volumn 48, Issue 5, 2009, Pages 490-496

  Cassim, Bilkish ^a   Shaw, Odette M ^b   Mazur, Margaret ^c   Misso, Neil L ^b   Naran, Anupam ^d   Langlands, Daniel R ^c   Thompson, Philip J ^b   Bhoola, Kanti D ^a,b,c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Kallikreins; Kinin receptors; Kininogen; Kinins; Neutrophils; RA; Synovium; Tender and swollen joints

Indexed keywords

KALLIKREIN; KININ; KININOGEN;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KALLIKREIN-KININ SYSTEM; KALLIKREINS; KININOGENS; KININS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEUTROPHILS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; SYNOVIAL FLUID; YOUNG ADULT;

EID: 65249098594     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep016     Document Type: Article

References (44)

1. Andersson AK, Li C, Brennan FM. Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Res Ther 2008;10:204.
2. Weyand CM, Goronzy JJ. Pathogenesis of rheumatoid arthritis. Med Clin North Am 1997;81:29-55.
3. Firestein GS. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J Clin Rheumatol 2005;11(Suppl. 3):S39-44.
4. Cassim B, Mody G, Bhoola K. Kallikrein cascade and cytokines in inflamed joints. Pharmacol Ther 2002;94:1-34.
5. Joseph K, Kaplan AP. Formation of bradykinin: A major contributor to the innate inflammatory response. Adv Immunol 2005;86:159-208.
6. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: Kallikreins, kininogens and kininases. Pharmacol Rev 1992;44:1-80.
7. Henderson LM, Figueroa CD, Müller-Esterl W, Stain A, Bhoola KD. Immunovisualisation of plasma prekallikrein and H-kininogen on human neutrophils and in human hepatocytes. Agents Actions Suppl 1992;38:590-4.
8. Henderson LM, Figueroa CD, Müller-Esterl W, Bhoola KD. Assembly of contact-phase factors on the surface of the human neutrophil membrane. Blood 1994;84:474-82.
9. Figueroa CD, MacIver AG, Bhoola KD. Identification of a tissue kallikrein in human polymorphonuclear leucocytes. Br J Haematol 1989;72:321-8.
10. Kemme M, Podlich D, Raidoo DM, Snyman C, Naidoo S, Bhoola KD. Identification of immunoreactive tissue prokallikrein on the surface membrane of human neutrophils. Biol Chem 1999;380:1321-8.
11. Bhoola KD, Elson CJ, Dieppe PA. Kinins - key mediators in inflammatory arthritis? Br J Rheumatol 1992;31:509-18.
12. Rahman MM, Bhoola KD, Elson CJ, Lemon M, Dieppe PA. Identification and functional importance of plasma kallikrein in the synovial fluids of patients with rheumatoid, psoriatic, and osteoarthritis. Ann Rheum Dis 1995;54:345-50.
13. Selwyn BM, Figueroa CD, Fink E, Swan A, Dieppe PA, Bhoola KD. A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis. Ann Rheum Dis 1989;48: 128-33.
14. Williams RJ, Henderson LM, Naidoo Y, Cassim B, Elson CJ, Bhoola KD. Immunocytochemical analysis of tissue kallikrein and the kinin moiety in rheumatoid synovial fluid neutrophils. Br J Rheumatol 1997;36:420-5.
15. Rahman MM, Lemon MJ, Elson CJ, Dieppe PA, Bhoola KD. Proinflammatory role of tissue kallikrein in modulating pain in inflamed joints. Br J Rheumatol 1995; 34:88-90.
16. Tiffany CW, Burch RM. Bradykinin stimulates tumour necrosis factor and interleukin-1 release from macrophages. FEBS Lett 1989;247:189-92.
17. Ljunggren O, Lerner UH. Evidence for BK1 bradykinin-receptor-mediated prostaglandin formation in osteoblasts and subsequent enhancement of bone resorption. Br J Pharmacol 1990;101:382-6.
18. Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL. International union of pharmacology. XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005;57:27-77.
19. Cassim B, Naidoo S, Naidoo Y, Williams R, Bhoola KD. Immunolocalization of the kinin moiety and bradykinin (B2) receptors on synovial fluid neutrophils in rheumatoid arthritis. Immunopharmacology 1996;33:321-4.
20. Cassim B, Naidoo S, Ramsaroop R, Bhoola KD. Immunolocalization of bradykinin receptors on human synovial tissue. Immunopharmacology 1997;36:121-5.
21. Fuchs HA, Brooks RH, Callahan LF, Pincus T. A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 1989;32:531-7.
22. Haasemann M, Buschko J, Faussner A et al. Anti-idiotypic antibodies bearing the internal image of a bradykinin epitope. Production, characterization, and interaction with the kinin receptor. J Immunol 1991;147:3882-92.
23. Fink E, Bhoola KD, Snyman C, Neth P, Figueroa CD. Cellular expression of plasma prekallikrein in human tissues. Biol Chem 2007;388:957-63.
24. Snyman CJ, Raidoo DM, Bhoola KD. Localization of proteases and peptides by confocal microscopy. Methods Enzymol 1999;307:368-94.
25. Bond AP, Lemon M, Dieppe PA, Bhoola KD. Generation of kinins in synovial fluid from patients with arthropathy. Immunopharmacology 1997;36:209-16.
26. Albano J, Bhoola KD, Harvey RF. Intracellular messenger role of cyclic GMP in exocrine pancreas. Nature 1976;262:404-6.
27. Carlsson J, Drevin H, Axen R. Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J 1978;173:723-37.
28. Plendl J, Snyman C, Naidoo S, Sawant S, Mahabeer R, Bhoola KD. Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells. Biol Chem 2000;381:1103-15.
29. Rahman MM, Worthy K, Elson CJ, Fink E, Dieppe PA, Bhoola KD. Inhibitor regulation of tissue kallikrein activity in the synovial fluid of patients with rheumatoid arthritis. Br J Rheumatol 1994;33:215-23.
30. Naidoo Y, Naidoo S, Nadar R, Bhoola KD. Role of neutrophil kinin in infection. Immunopharmacology 1996;33:387-90.
31. Haasemann M, Figueroa CD, Henderson L et al. Distribution of bradykinin B2 receptors in target cells of kinin action. Visualization of the receptor protein in A431 cells, neutrophils and kidney sections. Braz J Med Biol Res 1994;27:1739-56.
32. Hecquet C, Tan F, Marcic BM, Erdos EG. Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases. Mol Pharmacol 2000;58:828-36.
33. 8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat. Pain 1993;53:191-7.
34. 1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br J Pharmacol 1994;113:940-4.
35. Sharma JN, Wirth KJ. Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikreins. Gen Pharmacol 1996;27:133-6.
36. Stewart JM, Gera L, York EJ, Chan DC, Bunn P. Bradykinin antagonists: present progress and future prospects. Immunopharmacology 1999;43:155-61.
37. Frank MM, Jiang H. New therapies for hereditary angioedema: Disease outlook changes dramatically. J Allergy Clin Immunol 2008;121:272-80.
38. Zuraw BL, Christiansen SC. New promise and hope for treating hereditary angioedema. Expert Opin Investig Drugs 2008;17:697-706.
39. Mahabeer R, Bhoola KD. Kallikrein and kinin receptor genes. Pharmacol Ther 2000;88:77-89.
40. 2 receptor expression in neutrophils of asthmatic and non-asthmatic subjects. Int Immunopharmacol 2007;7:1862-8.
41. Chercuitte F, Beaulieu AD, Poubelle P, Marceau F. Carboxypeptidase N (kininase I) activity in blood and synovial fluid from patients with arthritis. Life Sci 1987;41:1225-32.
42. Sheikh IA, Kaplan AP. Assessment of kininases in rheumatic diseases and the effect of therapeutic agents. Arthritis Rheum 1987;30:138-45.
43. Bhoola KD, Misso NL, Naran A, Thompson PJ. Current status of tissue kallikrein inhibitors: Importance in cancer. Curr Opin Investig Drugs 2007;8:462-8.
44. Morissette G, Houle S, Gera L, Stewart JM, Marceau F. Antagonist, partial agonist and antiproliferative actions of B-9870 (CU201) as a function of the expression and density of the bradykinin B1 and B2 receptors. Br J Pharmacol 2007;150:369-79.